Tus kws kho mob
P56-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective January 7, 2019
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2791 - 2800 ntawm 4205
Tus kws kho mob
P53R1-18 Minnesota Health Care Programs Policies Effective December 1, 2018
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P52R1-18 Revised: 2019 Minnesota Medicare Network Update
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P31-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective September 3, 2018
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2018
Tus kws kho mob
P56-17 Implementation of a Medical Drug Exclusions List
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 16, 2017
Tus kws kho mob
P5R1-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 05, 2017
Tus kws kho mob
P50-16 Addition of a Drug (Xiidra) to the Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 28, 2016
Tus kws kho mob
P53-16 New Notification Requirement for Outpatient Dialysis Services for Commercial Products and Subscribers in Government Programs
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 09, 2016
Tus kws kho mob
P43R1-16 Updated: Third Party Payments of Premium and/or Cost-Sharing
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2016
Tus kws kho mob
P6-17 A New Drug, Emflaza (deflazacort), Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 27, 2017